A muscle mass in a patient with polymyalgia rheumatica
2018, doi: 10.1007/s00296-018-4142-x Chourpiliadis, C., et al, "Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral Sclerosis," JAMA Network Open, June 4, 2024, doi:10.1001/jamanetworkopen.2025.14437 Meron, M.K., et al, "GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes," Journal of Clinical Endocrinology & Metabolism, Feb.10, 2026, doi: 10.1210/clinem/dgag056 Luo, Y., et al, "GLP-1 receptor agonists in eye disease: a comprehensive review of current research and future potential," BMC Ophthalmology, Jan
Prescription medicines that act on this pathway are regulated drugs with standardized dosing and clinical trial data behind them
Food and Drug Administration (FDA) for use in treating T2DM
The high prevalence of metabolic disorders and early adoption of novel therapeutics contribute to the regional market dominance
We computed the top 20 PCs using bigsnpr R software with default parameters